CG Oncology CGON
NASDAQ CGON
$71.40 +0.89 (+1.25%)
As of: Sep 30, 2026 · 10:25 AM EDT

CG Oncology (CGON) Total Non-Current Liabilities (2024 - 2026)

Updated

CG Oncology's Total Non-Current Liabilities was $55.38 million in Q2 2026, up 31.8% from the prior quarter.

Analysis

CG Oncology (CGON) Total Non-Current Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025, Total Non-Current Liabilities at CG Oncology came in at $37.25 million, up 73.9% from FY2024.

  • In earlier years, Total Non-Current Liabilities was $21.42 million in FY2024.
  • Per Business Quant data, CGON's Total Non-Current Liabilities in the three quarters before Q2 2026 was $42.03 million (Q1 2026), $37.25 million (Q4 2025) and $38.47 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 105.99 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 106.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -967.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 5.92 Bn
10 CG Oncology 6.15 Bn 6.15 Bn -2.77 Mn 55.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 55.38 Mn
Mar 31, 2026 42.03 Mn
Dec 31, 2025 37.25 Mn
Sep 30, 2025 38.47 Mn
Dec 31, 2024 21.42 Mn
API Access

CG Oncology Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CGON&period=max&api_key=YOUR_API_KEY